WPC
VRTX icon

Wedmont Private Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Wedmont Private Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.91M Buy
3,792
+268
+8% +$137K 0.05% 216
2026
Q2 		$1.71M Buy
3,524
+141
+4% +$62.5K 0.05% 219
2026
Q1 		$1.5M Buy
3,383
+165
+5% +$76.9K 0.05% 220
2025
Q4 		$1.56M Sell
3,218
-81
-2% -$34.9K 0.05% 200
2025
Q3 		$1.35M Sell
3,299
-1,985
-38% -$830K 0.05% 217
2025
Q2 		$2.53M Buy
5,284
+929
+21% +$428K 0.11% 114
2025
Q1 		$2.11M Buy
4,355
+722
+20% +$336K 0.11% 113
2024
Q4 		$1.49M Buy
3,633
+384
+12% +$178K 0.08% 152
2024
Q3 		$1.46M Buy
3,249
+65
+2% +$31.2K 0.08% 147
2024
Q2 		$1.56M Buy
3,184
+126
+4% +$54.7K 0.1% 125
2024
Q1 		$1.24M Buy
3,058
+213
+7% +$90K 0.09% 145
2023
Q4 		$1.19M Buy
2,845
+342
+14% +$126K 0.1% 135
2023
Q3 		$889K Buy
2,503
+235
+10% +$82.2K 0.09% 144
2023
Q2 		$800K Buy
2,268
+489
+27% +$165K 0.09% 157
2023
Q1 		$575K Sell
1,779
-131
-7% -$39.3K 0.08% 196
2022
Q4 		$554K Buy
1,910
+308
+19% +$93.9K 0.08% 187
2022
Q3 		$464K Buy
1,602
+330
+26% +$94.9K 0.09% 172
2022
Q2 		$358K Buy
1,272
+310
+32% +$83K 0.08% 195
2022
Q1 		$258K Buy
+962
New +$228K 0.06% 260

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Wedmont Private Capital's VRTX Position: Q3 2026 in Review

Wedmont Private Capital increased its Vertex Pharmaceuticals (VRTX) stake by 7.6% in Q3 2026, buying an estimated $137K and bringing the position to 3,792 shares worth $1.91M. The position accounts for 0.05% of the portfolio, ranked #216.

Wedmont Private Capital first reported a position in VRTX in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.53M in Q2 2025. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Wedmont Private Capital held 3,792 shares of Vertex Pharmaceuticals worth $1.91M as of Q3 2026.
  • Wedmont Private Capital bought 268 Vertex Pharmaceuticals shares in Q3 2026, an estimated $137K.
  • Vertex Pharmaceuticals made up 0.05% of Wedmont Private Capital's portfolio in Q3 2026, its #216 holding.
  • Wedmont Private Capital first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
  • Wedmont Private Capital's Vertex Pharmaceuticals position peaked at $2.53M in Q2 2025.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.